drugset / Trial / NCT06488001

Preoperative Use of Pantoprazole for Prevention of Post Operative Nausea and Vomiting in Gynecologic Surgery

NCT06488001

Phase 2 Recruiting 132 enrolled United States Naval Medical Center, Portsmouth
RandomizedParallel-groupTriple-blindPrevention

Summary

The goal of this clinical trial is to see if pantoprazole (a proton pump inhibitor used for acid reflux/heart burn) can reduce nausea and vomiting after gynecologic surgery in women between the ages of 18 and 79. Researchers will compare a placebo to the active medication. Participants will be asked to take three pills around their surgery, two taken before and one taken the night after.

Timeline

Start
2022-08-26
Primary completion
2026-12
Completion
2026-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pantoprazole Other / unclassified 40 mg Oral

Indications

No indication recorded.